A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	WO2002014464B1 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
11/21/2002	WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002	US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002	US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002	US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002	US20020173551 Bupropion to treat viral diseases
11/21/2002	US20020173540 Using plant extract
11/21/2002	US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002	US20020173517 4-Oxoquinolizine antimicrobial having 2-pyridone skeleton as partial structure
11/21/2002	US20020173515 Antiproliferative agents
11/21/2002	US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002	US20020173499 Estrogen replacement therapy
11/21/2002	US20020173491 Viricides; drug resistance mixtures
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172940 Methods and reagents for isolating biologically active peptides
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172687 Anti-Viral Treatment With Pertussis Toxin B Oligomer
11/21/2002	US20020172686 Used for therapy or prophylaxis of fish diseases, feeds for animals
11/21/2002	US20020172682 Using heat shock proteins to increase immune response
11/21/2002	US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2460603A1 Unigene unidirectional antisense library
11/21/2002	CA2451116A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447444A1 Antisense permeation enhancers
11/21/2002	CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	CA2447286A1 Random gene unidirectional antisense library
11/21/2002	CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002	CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	CA2446839A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	CA2446704A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2446589A1 Methods for treating cancer
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	CA2445606A1 Taste masking pharmaceutical composition
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/20/2002	EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2002	EP1258478A1 Process for producing quinolonecarboxylic acids and intermediates thereof
11/20/2002	EP1258474A2 Alkylamide compounds
11/20/2002	EP1257817A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines
11/20/2002	EP1257650A1 Polymerase compositions and methods of use thereof
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257569A2 Cold-adapted equine influenza viruses
11/20/2002	EP1257568A1 Novel echinocandin derivatives, preparation method and use thereof as fungicides
11/20/2002	EP1257567A2 Cationic, amphipathic beta-sheet peptides and uses thereof
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257558A1 Methods for synthesis of alpha-d-gal (1- 3) gal-containing oligosaccharides
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257538A2 9-alkylamino-1-nitroacridine derivatives
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257295A2 Factor vii or viia-like molecules
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257288A1 Method for regulating il-10 with il-9, and applications thereof
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	EP1257276A1 Antiviral azaindole derivatives
11/20/2002	EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002	EP1257248A1 Pharmaceutical composition
11/20/2002	EP1206582A4 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/20/2002	EP0882049B1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/20/2002	EP0845992B1 Use of relaxin for promoting angiogenesis
11/20/2002	EP0833828B1 Rapamycin derivatives
11/20/2002	EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/20/2002	EP0656360B1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
11/20/2002	EP0652772B1 Herpesvirus vaccines
11/20/2002	CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/20/2002	CN1380422A Method for defining molecule being involved in adhesion and vaccine containing immunogenic peptide identified by said method
11/20/2002	CN1380413A Human 6-phosphoglucosamine isomerase, its code sequence and application
11/20/2002	CN1380407A New human-phosphoguanosine reductase, its coding sequence and application
11/20/2002	CN1380102A Biological preparation medicine modulated by micro-alternating biological electric field for curing AIDS and its production method
11/20/2002	CN1380100A Biological immunomodulator for animal for curing and preventing foot and mouth disease and its production method
11/20/2002	CN1380098A Anti-infection compound preparation and its preparation method
11/20/2002	CN1380094A Achillea total flavone capsule
11/20/2002	CN1380082A Chinese medicine for curing female chronic inflammation

1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 1798